BioCentury
ARTICLE | Company News

AIBioTech sales and marketing update

February 11, 2013 8:00 AM UTC

The company launched its LDT asparaginase assay in the U.S. and Canada. The assay measures L-asparaginase levels in patients receiving asparaginase-based drugs for acute lymphoblastic leukemia (ALL). ...